B cell Therapy to Treat an Axonal Neuropathy in Mixed Connective Tissue Disease
The B cell is a vital contributor to humoral immunity. The B cell-specific antigen CD20 is expressed during B cell development, starting at the pre-B cell level and persists through B cell differentiation, but is lost during terminal differentiation to plasma cells. Rituximab is a monoclonal antibo...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Guilan University of Medical Sciences
2017-02-01
|
Series: | Caspian Journal of Neurological Sciences |
Subjects: | |
Online Access: | http://cjns.gums.ac.ir/browse.php?a_code=A-10-32-65&slc_lang=en&sid=1 |